ENT

Your Article Summary

See Latest Articles

Using a cross-cheek anterolateral thigh flap for simultaneous correction of trismus and oral cancer
Journal of Plastic, Reconstructive & Aesthetic Surgery, 07/06/09

Chen CC et al. - In a study to assess the use of a novel surgical approach using a cross-cheek anterolateral thigh (ALT) flap for simultaneous correction of trismus and oral cancer, it was concluded that this innovative design could be a viable option in the management of trismus and oral cancer.

• Oral cancers in association with trismus are commonly seen in clinical practice.
• Such a situation deserves special attention as it may complicate tumour-ablative surgery and interfere with postoperative cancer surveillance.
• Simultaneous tackling of oral cancer and trismus should be pursued at any rate.
• In this article, a novel surgical approach using a cross-cheek ALT flap is introduced.

• With the special design in length, shape, and orientation, this flap is capable of closing a wider defect area, sometimes extending across 2 functional regions (viz., posterior palate and trigonal area) without resort to 2 free flaps.
• As such, complex defects resulting from trismus release and tumour ablation can be readily repaired in a single stage.
• The advantages of such a technique include abundance in soft-tissue resources, proper flap quality and thickness, reliable blood supply, long and sizeable pedicle, ease in flap inset, need for only 1 recipient rather than 2, and eradication of large area of mucosa that is predisposed to malignant transformation.

Related Articles

See all related articles

Oral cancer and polymorphism of ethanol metabolising genes
Oral Oncology, 11/12/09    Relevance Score: 70%

Quantification of betel quid chewing and cigarette smoking in oral cancer patients
Community Dentistry and Oral Epidemiology, 11/17/09    Relevance Score: 69%

Transactivation and expression patterns of Jun and Fos/AP-1 super-family proteins in human oral cancer
International Journal of Cancer, 11/10/09    Relevance Score: 68%

Saliva as a tool for oral cancer diagnosis and prognosis
Oral Oncology, 10/21/09    Relevance Score: 68%

Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer
Journal of Clinical Oncology, 10/16/09    Relevance Score: 68%

Today in Oral Cavity...keeping you current

Receive free subspecialty "5-minute updates" via email

Microbiology of third and fourth branchial pouch cysts
The Laryngoscope, 12/16/09

Comparative analysis of slot dimension in lingual bracket systems
Head & Face Medicine, 12/16/09

Outcomes of salvage surgery with free flap reconstruction for recurrent oral and oropharyngeal cancer
The Laryngoscope, 12/11/09

 See all of Oral Cavity

Today in Plastic/Reconstructive...keeping you current

Receive free subspecialty "5-minute updates" via email

Single dose of preoperative analgesia with gabapentin (600 mg) is safe and effective in monitored anesthesia care for nasal surgery
European Archives of Oto-Rhino-Laryngology, 12/16/09

Skin necrosis in nasal dorsum following rhinoplasty
European Journal of Plastic Surgery, 12/16/09

Impact of thyroidectomy without laryngeal nerve injury on vocal quality characteristics: An objective multiparameter approach
The Laryngoscope, 12/15/09

 See all of Plastic/Reconstructive